Onera Health

𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗶𝗻𝗴 𝗔𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝗣𝗦𝗚 — 𝗔𝗻𝘆𝘄𝗵𝗲𝗿𝗲, 𝗔𝗻𝘆𝘁𝗶𝗺𝗲 𝗦𝗹𝗲𝗲𝗽 𝗥𝗲𝘃𝗶𝗲𝘄 𝗠𝗮𝗴𝗮𝘇𝗶𝗻𝗲 has published its latest 𝗛𝗼𝗺𝗲 𝗦𝗹𝗲𝗲𝗽 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗗𝗲𝘃𝗶𝗰𝗲 𝗚𝘂𝗶𝗱𝗲, highlighting innovations that bring varying levels of sleep diagnostics into the home. 𝘙𝘦𝘢𝘥 𝘵𝘩𝘦 𝘢𝘳𝘵𝘪𝘤𝘭𝘦: https://lnkd.in/gSnJvsAC The 𝗢𝗻𝗲𝗿𝗮 𝗦𝗧𝗦 enables 𝗽𝗼𝗹𝘆𝘀𝗼𝗺𝗻𝗼𝗴𝗿𝗮𝗽𝗵𝘆 𝗮𝘁 𝗵𝗼𝗺𝗲 (𝗵𝗣𝗦𝗚) through a 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗮𝗽𝗽𝗹𝗶𝗲𝗱, 𝗽𝗮𝘁𝗰𝗵-𝗯𝗮𝘀𝗲𝗱 𝘀𝘆𝘀𝘁𝗲𝗺 that delivers equivalent accuracy to the gold standard of in-lab PSG. The 𝗢𝗻𝗲𝗿𝗮 𝗵𝗣𝗦𝗚 𝘀𝘆𝘀𝘁𝗲𝗺 expands access, reduces time to diagnosis, and empowers clinicians to deliver high-quality sleep diagnostics efficiently in the comfort of the patient’s natural sleeping environment. #sleepmedicine #sleepreview #hPSG #sleepdiagnostics

𝗗𝗼 𝘁𝗵𝗲 𝗮𝘁𝘆𝗽𝗶𝗰𝗮𝗹 𝘀𝗹𝗲𝗲𝗽 𝗱𝗶𝘀𝗼𝗿𝗱𝗲𝗿 𝘀𝘆𝗺𝗽𝘁𝗼𝗺𝘀 𝘄𝗮𝗿𝗿𝗮𝗻𝘁 𝗣𝗦𝗚 𝘀𝗰𝗿𝗲𝗲𝗻𝗶𝗻𝗴 𝗶𝗻 𝘄𝗼𝗺𝗲𝗻? For many women, midlife means restless nights. The menopausal transition reshapes sleep through hormones, hot flashes, mood, and behavior.   Up to half of these women report significant sleep difficulties. About 1 in 4 meet the full criteria for insomnia. The most frequent complaint is waking several times per night and struggling to get back to sleep. Hot flashes and night sweats are triggers, and mood symptoms or stress can intensify the perception of poor rest (1). Other sleep disorder symptoms in women include:  • 𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗶𝗻𝗴 𝗦𝗗𝗕 𝗮𝗻𝗱 𝗽𝗲𝗿𝗶𝗼𝗱𝗶𝗰 𝗹𝗶𝗺𝗯 𝗺𝗼𝘃𝗲𝗺𝗲𝗻𝘁𝘀 𝗮𝗳𝘁𝗲𝗿 𝗺𝗲𝗻𝗼𝗽𝗮𝘂𝘀𝗲 (𝟮)  • 𝗔𝗯𝗼𝘂𝘁 𝟰𝟳%–𝟲𝟳% 𝗼𝗳 𝗽𝗼𝘀𝘁𝗺𝗲𝗻𝗼𝗽𝗮𝘂𝘀𝗮𝗹 𝘄𝗼𝗺𝗲𝗻 𝗵𝗮𝘃𝗲 𝗢𝗦𝗔, 𝗼𝗳𝘁𝗲𝗻 𝘄𝗶𝘁𝗵 𝗮𝗻 𝗮𝘁𝘆𝗽𝗶𝗰𝗮𝗹 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻, 𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗼 𝘂𝗻𝗱𝗲𝗿𝗿𝗲𝗰𝗼𝗴𝗻𝗶𝘁𝗶𝗼𝗻 𝗼𝗿 𝗺𝗶𝘀𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 (𝟰)  • 𝗢𝗦𝗔 𝗶𝘀 𝗥𝗘𝗠 𝘀𝗹𝗲𝗲𝗽 𝗽𝗿𝗲𝗱𝗼𝗺𝗶𝗻𝗮𝗻𝘁 (𝟯)  • 𝗔 𝗹𝗼𝘄𝗲𝗿 𝗮𝗿𝗼𝘂𝘀𝗮𝗹 𝘁𝗵𝗿𝗲𝘀𝗵𝗼𝗹𝗱 𝘁𝗵𝗮𝗻 𝗺𝗲𝗻, 𝗿𝗲𝘀𝘂𝗹𝘁𝗶𝗻𝗴 𝗶𝗻 𝗳𝗲𝘄𝗲𝗿 𝗮𝗽𝗻𝗲𝗮𝘀 𝗼𝗿 𝗵𝘆𝗽𝗼𝗽𝗻𝗲𝗮𝘀 (𝟰)  • 𝗔 𝗹𝗼𝘄𝗲𝗿 𝗔𝗛𝗜 𝗰𝗼𝗺𝗽𝗮𝗿𝗲𝗱 𝘁𝗼 𝗺𝗲𝗻 (𝟰), 𝗮𝗻𝗱 𝗮 𝟰% 𝗔𝗛𝗜 𝗶𝗻𝗰𝗿𝗲𝗮𝘀𝗲 𝗳𝗼𝗿 𝗲𝘃𝗲𝗿𝘆 𝗮𝗱𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝘆𝗲𝗮𝗿 𝘀𝗶𝗻𝗰𝗲 𝗲𝗻𝘁𝗲𝗿𝗶𝗻𝗴 𝘁𝗵𝗲 𝗺𝗲𝗻𝗼𝗽𝗮𝘂𝘀𝗮𝗹 𝘁𝗿𝗮𝗻𝘀𝗶𝘁𝗶𝗼𝗻 (𝟭) PSG screening may therefore be warranted in women with suspected SDB. The International Consensus Statement (3) and menopause-focused reviews (4) note that Home Sleep Apnea Testing lacks EEG-based sleep staging and may underestimate REM predominant or subtle SDB. A PSG evaluation for OSA should be considered when individuals report snoring together with awakenings from sleep, unrefreshing sleep, and/or daytime sleepiness (2). Onera Health is looking forward to the learnings from the November AASM Women’s Sleep Health Summit contributing to this discussion. #WomensHealth #Insomnia #SleepMedicine #HomePSG #SleepDiagnostics #OneraHealth   1.Baker FC, et al. Nature and Science of Sleep. 2018;10:73–95. doi:10.2147/NSS.S125807. 2. Joffe H, et al. Semin Reprod Med. 2010; 28(5): 404–421. doi:10.1055/s-0030-1262900. 3. Chang JL, et al. Nat Sci Sleep. 2023;15:221-254. doi:10.2147/NSS.S3953784. 4. Ray 2025. Clin. J. Nurse Practitioners in Women’s Health. 2025. doi: 10.1891/CJNPWH-2501 

Onera Health 𝗶𝘀 𝗵𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗼 𝘁𝗵𝗲 𝗖𝗮𝗹𝗶𝗳𝗼𝗿𝗻𝗶𝗮 𝗦𝗹𝗲𝗲𝗽 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟯-𝟰! Onera’s mission is to deliver 𝗣𝗦𝗚 𝗔𝗻𝘆𝘁𝗶𝗺𝗲, 𝗔𝗻𝘆𝘄𝗵𝗲𝗿𝗲 with our 𝗵𝗣𝗦𝗚 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻 that provides the same high-quality diagnostic data as in-lab studies, without the need for extra staff or capital. With Onera’s PSG-as-a-Service, sleep professionals can: • Scale PSG testing efficiently • Reduce PSG backlog to reduce time to diagnosis and therapy • Offer a more patient-friendly experience in the home setting See how our 𝗣𝗦𝗚-𝗮𝘀-𝗮-𝗦𝗲𝗿𝘃𝗶𝗰𝗲 solution is helping sleep centers expand access to PSG to those patients requiring the gold standard in sleep diagnostics. Stop by our booth at 𝗖𝗦𝗦 𝟮𝟬𝟮𝟱 and let’s talk about the future of sleep diagnostics. #SleepMedicine #HomePSG #CSS #SleepHealth #PSGAnywhere #Onera

𝗘𝗥𝗦 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝟮𝟬𝟮𝟱 | 𝗧𝗵𝗲 𝗢𝗻𝗲𝗿𝗮 𝗦𝗧𝗦 𝗵𝗼𝗺𝗲 𝗣𝗦𝗚 will be featured during two skills workshops at 𝗘𝗥𝗦 𝟮𝟬𝟮𝟱 (𝗔𝗺𝘀𝘁𝗲𝗿𝗱𝗮𝗺, 𝟮𝟳 𝗦𝗲𝗽𝘁 – 𝟭 𝗢𝗰𝘁). 𝗦𝘂𝗻𝗱𝗮𝘆, 𝟮𝟴 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟱 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝘁𝗲𝗰𝗵𝗻𝗶𝗾𝘂𝗲𝘀 𝗳𝗼𝗿 𝘀𝗹𝗲𝗲𝗽 𝗯𝗿𝗲𝗮𝘁𝗵𝗶𝗻𝗴 𝗱𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀 • Skills workshop 6: 09.00 • Skills workshop 7: 14.00 This hands-on workshop will explore: • The role and limitations of different levels of sleep studies in diagnosing sleep-related breathing disorders. • Practical interpretation of adult and pediatric poly(somno)graphs. • Insights into sleep studies under therapy (CPAP, ASV, NIV). The inclusion of 𝗢𝗻𝗲𝗿𝗮 𝗦𝗧𝗦 highlights its value as an innovative, scalable solution that expands access to the gold-standard PSG by delivering the accuracy of PSG directly into the patients home —̶bringing high-quality diagnostics closer to both clinicians and the patients they serve. The workshops will be led by 𝗣𝗿𝗼𝗳. 𝗗𝗿. 𝗟𝘂𝗱𝗴𝗲𝗿 𝗚𝗿𝗼𝘁𝗲 and 𝗗𝗿. 𝗗𝗶𝗻𝗴 𝗭𝗼𝘂, both from the 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 𝗼𝗳 𝗚𝗼𝘁𝗵𝗲𝗻𝗯𝘂𝗿𝗴. Prof. Grote brings over 30 years of expertise in respiratory sleep medicine, with research focused on diagnostic devices, biosignals, and international collaborations such as ESADA and the EU-funded 𝘚𝘭𝘦𝘦𝘱 𝘙𝘦𝘷𝘰𝘭𝘶𝘵𝘪𝘰𝘯. Dr. Zou specializes in cardiovascular regulation during sleep, OSA pharmacotherapy, and the use of physiological signals for endotyping and risk assessment, while also serving in key leadership roles within ESRS and SFSS. Register: https://lnkd.in/dQhuPKA #ERSCongress #SleepDiagnostics #OSA #Polysomnography #RespiratoryMedicine #InnovationInSleep

At Onera Health , we believe better sleep starts with better insights. By raising awareness and improving access to accurate sleep diagnostics, we can shorten the path to diagnosis, reduce stigma, and help people living with narcolepsy feel seen and supported. Each year on 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟮𝟮, the international narcolepsy community comes together to raise awareness of this often misunderstood conditionand elevating the voices of the 𝟯 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗽𝗲𝗼𝗽𝗹𝗲 𝗹𝗶𝘃𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝗻𝗮𝗿𝗰𝗼𝗹𝗲𝗽𝘀𝘆 𝘄𝗼𝗿𝗹𝗱𝘄𝗶𝗱𝗲. 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗻𝗮𝗿𝗰𝗼𝗹𝗲𝗽𝘀𝘆?  Narcolepsy is a chronic neurological condition that impairs the brain’s ability to regulate the sleep–wake cycle. People may experience: • Excessive daytime sleepiness • Sudden loss of muscle tone (cataplexy) • Sleep paralysis • Vivid hallucinations 𝗪𝗵𝘆 𝗮𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗺𝗮𝘁𝘁𝗲𝗿𝘀 Despite affecting approximately 𝟭 𝗶𝗻 𝟮,𝟬𝟬𝟬 𝗽𝗲𝗼𝗽𝗹𝗲, narcolepsy remains widely underdiagnosed and misunderstood—even within the medical field. On average, patients wait 𝟴–𝟭𝟱 𝘆𝗲𝗮𝗿𝘀 from symptom onset to diagnosis. Many are misdiagnosed with psychiatric or other sleep disorders before receiving the right care.  By raising awareness, we can: • 𝗥𝗲𝗱𝘂𝗰𝗲 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗱𝗲𝗹𝗮𝘆𝘀 through better recognition of symptoms. • 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲 𝘀𝘁𝗶𝗴𝗺𝗮 𝗮𝗻𝗱 𝗺𝗶𝘀𝗰𝗼𝗻𝗰𝗲𝗽𝘁𝗶𝗼𝗻𝘀 about what it means to live with narcolepsy. • 𝗜𝗺𝗽𝗿𝗼𝘃𝗲 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀 for people living with this invisible illness. Let’s work together to ensure patients feel 𝘀𝗲𝗲𝗻, 𝘀𝘂𝗽𝗽𝗼𝗿𝘁𝗲𝗱, 𝗮𝗻𝗱 𝗵𝗲𝗮𝗿𝗱. Join the conversation and help spread awareness using #𝗪𝗼𝗿𝗹𝗱𝗡𝗮𝗿𝗰𝗼𝗹𝗲𝗽𝘀𝘆𝗗𝗮𝘆. #NarcolepsyAwareness #SleepDisorder #NeurologicalCondition #InvisibleIllness #WakeUpToNarcolepsy #RareDisease #ChronicIllness #SleepAwareness

𝗪𝗵𝘆 𝘄𝗼𝗺𝗲𝗻 𝗮𝗿𝗲 𝘂𝗻𝗱𝗲𝗿𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗲𝗱 𝗳𝗼𝗿 𝘀𝗹𝗲𝗲𝗽-𝗱𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝗲𝗱 𝗯𝗿𝗲𝗮𝘁𝗵𝗶𝗻𝗴  Sleep-disordered breathing (SDB) does not look the same in women and men. According to the recent review by Schwarz & Schiza (2024) differences in prevalence, pathophysiology, and symptom presentation directly impact diagnosis and treatment. 𝗣𝗿𝗲𝘃𝗮𝗹𝗲𝗻𝗰𝗲: Obstructive Sleep Apnea (OSA) is twice as common in men up to age 50, but after menopause the prevalence in women increases and nearly matches that of men.  𝗣𝗮𝘁𝗵𝗼𝗽𝗵𝘆𝘀𝗶𝗼𝗹𝗼𝗴𝘆: Women have lower upper airway collapsibility and a lower arousal threshold than men: their airways collapse less, but they wake more easily.  𝗦𝘆𝗺𝗽𝘁𝗼𝗺𝘀 & 𝗰𝗼𝗺𝗼𝗿𝗯𝗶𝗱𝗶𝘁𝗶𝗲𝘀: Women with OSA more often present with fatigue, depression/anxiety, and insomnia (COMISA) while men typically report snoring and daytime sleepiness. Women are often symptomatic at lower apnea-hypopnea index (AHI) and OSA is more REM-predominant. They have more arousals and sleep fragmentation, more hypopneas than apneas, and less oxygen desaturation during Non-REM sleep compared with men. This leads to systematic underdiagnosis and undertreatment.  Polygraphy alone often misses female-typical phenotypes such as REM-OSA and Upper Airway Resistance Syndrome. Polysomnography (PSG) should therefore be considered in women with suspected sleep-disordered breathing (1). This is essential for accurate diagnosis, individualized management, and advancement of precision medicine in women’s health.  AASM has recently launched their comprehensive initiative to advance women’s sleep health with a Summit planned in early November. Onera Health supports this initiative and looks forward to the consensus coming from the discussion.  1. Schwarz E & Schiza I. Sex differences in sleep and sleep-disordered breathing. Current Opinion in Pulmonary Medicine, 2024; 30:593-599. DOI:  https://lnkd.in/eGz9yPj5 #WomensHealth #COMISA #SleepMedicine #HomePSG #SleepDiagnostics #OneraHealth

𝗚𝗹𝗼𝗯𝗮𝗹 𝗠𝗼𝗺𝗲𝗻𝘁𝘂𝗺 𝗠𝗲𝗲𝘁𝘀 𝗛𝗼𝗺𝗲 𝗣𝗦𝗚 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 Standard home testing in the U.S. remains limited to simple OSA detection. But Type II home PSG (hPSG) technology is capable of so much more. International clinicians are using Type II hPSG systems—not just for sleep apnea, but also to aid in the diagnosis of narcolepsy, bruxism, PLMD, and more. The primary barrier for its use in the US is adequate reimbursement, however, that is expected to change when new CPT codes are adopted. The anticipated reimbursement combined with Onera Health’s wireless, patch-based hPSG system will bring the gold standard of PSG into the home and thereby increase access and shorten the time to diagnosis and treatment. https://lnkd.in/egEBxvC5 #sleepdiagnostics #hPSG #polysomnography

A recent in-depth review published in 𝘉𝘪𝘰𝘴𝘦𝘯𝘴𝘰𝘳𝘴 (2025) outlines the growing clinical relevance of 𝘄𝗲𝗮𝗿𝗮𝗯𝗹𝗲 𝗮𝗻𝗱 𝗿𝗲𝗺𝗼𝘁𝗲 𝘀𝗹𝗲𝗲𝗽 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀, particularly in the context of 𝗵𝗼𝗺𝗲-𝗯𝗮𝘀𝗲𝗱 𝗽𝗼𝗹𝘆𝘀𝗼𝗺𝗻𝗼𝗴𝗿𝗮𝗽𝗵𝘆 (𝗣𝗦𝗚). The paper, "𝙏𝙧𝙖𝙣𝙨𝙛𝙤𝙧𝙢𝙞𝙣𝙜 𝙎𝙡𝙚𝙚𝙥 𝙈𝙤𝙣𝙞𝙩𝙤𝙧𝙞𝙣𝙜: 𝙍𝙚𝙫𝙞𝙚𝙬 𝙤𝙛 𝙒𝙚𝙖𝙧𝙖𝙗𝙡𝙚 𝙖𝙣𝙙 𝙍𝙚𝙢𝙤𝙩𝙚 𝘿𝙚𝙫𝙞𝙘𝙚𝙨 𝘼𝙙𝙫𝙖𝙣𝙘𝙞𝙣𝙜 𝙃𝙤𝙢𝙚 𝙋𝙤𝙡𝙮𝙨𝙤𝙢𝙣𝙤𝙜𝙧𝙖𝙥𝙝𝙮 𝙖𝙣𝙙 𝙏𝙝𝙚𝙞𝙧 𝙍𝙤𝙡𝙚 𝙞𝙣 𝙋𝙧𝙚𝙙𝙞𝙘𝙩𝙞𝙣𝙜 𝙉𝙚𝙪𝙧𝙤𝙡𝙤𝙜𝙞𝙘𝙖𝙡 𝘿𝙞𝙨𝙤𝙧𝙙𝙚𝙧𝙨", presents strong evidence that modern wearable systems—especially those integrating EEG, ECG, PPG, respiration monitoring, and actigraphy—are now approaching the diagnostic rigor traditionally reserved for lab-based PSG. 𝗞𝗲𝘆 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀: • Multi-sensor home-based systems can support 𝗰𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝘀𝗹𝗲𝗲𝗽 𝘀𝘁𝗮𝗴𝗶𝗻𝗴 and 𝗿𝗲𝘀𝗽𝗶𝗿𝗮𝘁𝗼𝗿𝘆 𝗲𝘃𝗲𝗻𝘁 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 • Sleep disturbances detectable via these tools may offer early biomarkers for 𝗻𝗲𝘂𝗿𝗼𝗱𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀 such as Alzheimer’s and Parkinson’s • Wearable PSG systems offer improved 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗰𝗼𝗺𝗳𝗼𝗿𝘁, 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲, and the ability to monitor sleep in naturalistic environments One example noted in the review is the 𝗽𝗮𝘁𝗰𝗵-𝗯𝗮𝘀𝗲𝗱 𝘄𝗶𝗿𝗲𝗹𝗲𝘀𝘀 𝗣𝗦𝗚 𝘀𝘆𝘀𝘁𝗲𝗺 𝗳𝗿𝗼𝗺 𝗢𝗻𝗲𝗿𝗮 𝗛𝗲𝗮𝗹𝘁𝗵 , which combines the gold standard signal quality of PSG with ease of use enabling unattended home PSG – potentially easing the significant challenges of limited bed capacity and the shortage of trained technicians facing sleep lab’s. 𝗧𝗵𝗶𝘀 𝘀𝗵𝗶𝗳𝘁 𝗼𝗽𝗲𝗻𝘀 𝗻𝗲𝘄 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 𝗳𝗼𝗿 𝗯𝗿𝗼𝗮𝗱𝗲𝗿 𝗮𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝗰𝗮𝗿𝗲, 𝗲𝗮𝗿𝗹𝗶𝗲𝗿 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 𝗼𝗳 𝗰𝗼𝗺𝗼𝗿𝗯𝗶𝗱 𝗻𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗰𝗼𝗻𝗱𝗶𝘁𝗶𝗼𝗻𝘀, 𝗮𝗻𝗱 𝗲𝗻𝗵𝗮𝗻𝗰𝗲𝗱 𝗽𝗲𝗿𝘀𝗼𝗻𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗽𝗮𝘁𝗵𝘄𝗮𝘆𝘀. Full article: https://lnkd.in/eYFZp5YH #SleepMedicine #Polysomnography #WearableTech #Neurodiagnostics #DigitalHealth #SleepDisorders #Onera #ClinicalInnovation #RemoteMonitoring

𝗕𝗲𝗮𝘁 𝗝𝗲𝘁 𝗟𝗮𝗴 𝗧𝗵𝗶𝘀 𝗦𝘂𝗺𝗺𝗲𝗿: 𝗦𝗰𝗶𝗲𝗻𝗰𝗲-𝗕𝗮𝗰𝗸𝗲𝗱 𝗧𝗶𝗽𝘀 𝗳𝗼𝗿 𝗧𝗿𝗮𝘃𝗲𝗹𝗲𝗿𝘀 As summer holidays approach, many of us are gearing up for travel. Crossing multiple time zones can disrupt your circadian rhythm, leading to jet lag symptoms such as fatigue, insomnia, mood swings and digestive problems. A recent systematic review by Ahmed et al. [1] offers science-backed strategies to help you stay energized and healthy during your travels. The circadian rhythm—our internal 24-hour clock—relies heavily on light and behavioural cues. Crossing time zones disrupts this rhythm. What can help?  • Morning light exposure after eastward travel or evening light after westward travel supports realignment.   • Meal and exercise timing also act as time cues that set your internal clock.  • Sleep Hygiene: Create a restful environment and stick to a consistent sleep schedule to improve overall sleep health.         Takeaway: Jet lag isn’t just about sleep; it’s a full-body shift. Plan your exposure to light, meals, and activity to help your brain adjust faster. Happy summer holidays! #JetLag #CircadianRhythm #Chronobiology #SleepScience #TravelHealth Source: 1.Ahmed O, et al. 2024. Cureus 16(10): e71316. DOI https://lnkd.in/e94PZ2pa

𝗛𝗼𝘄 𝗰𝗹𝗼𝘀𝗲 𝗮𝗿𝗲 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝘀𝗹𝗲𝗲𝗽 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝘀𝘆𝘀𝘁𝗲𝗺𝘀 𝘁𝗼 𝘁𝗿𝗮𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝘀𝗹𝗲𝗲𝗽 𝘀𝘁𝘂𝗱𝗶𝗲𝘀? A recent systematic review by De Gans et al. [1] analyzed 𝟯𝟰 𝗘𝗘𝗚-𝗯𝗮𝘀𝗲𝗱 𝘀𝗹𝗲𝗲𝗽 𝗺𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗱𝗲𝘃𝗶𝗰𝗲𝘀—from simple headbands and ear-EEG to comprehensive sensor patches and portable PSG systems. Their findings? These technologies are increasingly accurate in sleep staging and offer strong potential for at-home monitoring. 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘀𝘁𝗮𝗻𝗱𝗼𝘂𝘁: the 𝗢𝗻𝗲𝗿𝗮 𝗦𝗧𝗦 𝗛𝗼𝗺𝗲 𝗣𝗼𝗹𝘆𝘀𝗼𝗺𝗻𝗼𝗴𝗿𝗮𝗽𝗵𝘆 𝗦𝘆𝘀𝘁𝗲𝗺. Unlike basic EEG wearables, this comprehensive solution combines four sensors with a 𝗳𝘂𝗹𝗹 𝟭𝟱-𝗰𝗵𝗮𝗻𝗻𝗲𝗹 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹-𝗴𝗿𝗮𝗱𝗲 𝘀𝗶𝗴𝗻𝗮𝗹 𝘀𝗲𝘁 (EEG, EOG, EMG, ECG, respiratory signals, SpO₂) to deliver true polysomnography at home. Our 𝗹𝗮𝗻𝗱𝗺𝗮𝗿𝗸 𝗺𝘂𝗹𝘁𝗶𝗰𝗲𝗻𝘁𝗲𝗿 𝘃𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻 𝘀𝘁𝘂𝗱𝘆 recently published in the Journal of Clinical Sleep Medicine demonstrated exceptional performance [2]. With 𝟮𝟬𝟲 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝗻𝘁𝘀 across 𝘀𝗲𝘃𝗲𝗻 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘀𝗶𝘁𝗲𝘀 and scoring by 𝘁𝗵𝗿𝗲𝗲 𝗶𝗻𝗱𝗲𝗽𝗲𝗻𝗱𝗲𝗻𝘁 𝗰𝗲𝗿𝘁𝗶𝗳𝗶𝗲𝗱 𝗮𝗻𝗮𝗹𝘆𝘀𝘁𝘀, the Onera STS achieved: • 𝗛𝗶𝗴𝗵 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗮𝗰𝗰𝘂𝗿𝗮𝗰𝘆 𝗰𝗼𝗺𝗽𝗮𝗿𝗮𝗯𝗹𝗲 𝘁𝗼 𝗶𝗻-𝗹𝗮𝗯 𝗽𝗼𝗹𝘆𝘀𝗼𝗺𝗻𝗼𝗴𝗿𝗮𝗽𝗵𝘆 𝗮𝗰𝗿𝗼𝘀𝘀 𝗮𝗹𝗹 𝘀𝗹𝗲𝗲𝗽 𝘀𝘁𝗮𝗴𝗲𝘀 These results prove that 𝗢𝗻𝗲𝗿𝗮'𝘀 𝗵𝗼𝗺𝗲 𝗣𝗦𝗚 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘀 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗮𝗰𝗰𝘂𝗿𝗮𝗰𝘆 𝗰𝗼𝗺𝗽𝗮𝗿𝗮𝗯𝗹𝗲 𝘁𝗼 𝗶𝗻-𝗹𝗮𝗯 𝗽𝗼𝗹𝘆𝘀𝗼𝗺𝗻𝗼𝗴𝗿𝗮𝗽𝗵𝘆—a transformative advancement in comprehensive sleep diagnostics recognized now in leading systematic reviews. [1] De Gans et al., 2024 https://lnkd.in/enw3fmwW [2] Viniol C., et al. J Clin Sleep Med 2025. https://lnkd.in/eVTVmcsJ